Orlistat: current status in clinical therapeutics.

Expert opinion on drug safety

Volumn 8, Issue 6, 2009, Pages 727-744

  McClendon, Katie S ^a   Riche, Daniel M ^a   Uwaifo, Gabriel Ikponmosa ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; LACTONE; NON PRESCRIPTION DRUG; TETRAHYDROLIPSTATIN;

ANIMAL; DRUG APPROVAL; DRUG INTERACTION; FOOD AND DRUG ADMINISTRATION; HUMAN; META ANALYSIS; OBESITY; PATHOPHYSIOLOGY; POSTMARKETING SURVEILLANCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNITED STATES;

ANIMALS; ANTI-OBESITY AGENTS; DRUG APPROVAL; DRUG INTERACTIONS; HUMANS; LACTONES; META-ANALYSIS AS TOPIC; NONPRESCRIPTION DRUGS; OBESITY; PRODUCT SURVEILLANCE, POSTMARKETING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77449089907     PISSN: None     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740330903321485     Document Type: Review

References (169)